ExpreS2ion Biotech Holding AB (publ) (OM: EXPRS2)
Health Care · Biotechnology · SE
Skr1.04
-5.02% today · -94.7% 1Y
ExpreS2ion Biotech Holding AB (publ) (OM: EXPRS2) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.59M and employs 19 people.
Over the last twelve months the share price has lost 94.7%, trading between 1.04 and 22.85.
Tweenvest scores ExpreS2ion Biotech Holding AB (publ) across four factors: quality 36/100, value 50/100, growth 100/100. Its strongest factor is growth.
EXPRS2 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.59M
- Revenue (TTM)
- $2.50M
- P/E
- —
- EPS
- -1.51
- Dividend yield
- —
- Beta (5Y)
- 2.21
- 52-week high
- Skr22.85
- 52-week low
- Skr1.04
- Avg volume (3M)
- —
- Shares outstanding
- 23.75M
- Employees
- 19
- Next earnings
- —
About ExpreS2ion Biotech Holding AB (publ)
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
- ISIN
- SE0023261292
- Founded
- 2015
- Listed since
- Jul 29, 2016
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bioxytran, Inc.OTCPK: BIXT | $2.74M | $0.02 | +13.27% |
| BioRestorative Therapies, Inc.NasdaqCM: BRTX | $2.73M | $1.89 | -11.68% |
| Vaccinex, Inc.OTCPK: VCNX | $2.70M | $1.01 | +4.12% |
| Spermosens AB (publ)NGM: SPERM | $2.67M | Skr0.01 | -2.33% |
| Matinas BioPharma Holdings, Inc.NYSEAM: MTNB | $2.59M | $2.83 | +7.20% |
| Sunshine Biopharma, Inc.NasdaqCM: SBFM | $2.58M | $0.43 | -35.48% |
| Enzolytics, Inc.OTCPK: ENZC | $2.42M | $0.00 | +25.00% |
| CASI Pharmaceuticals, Inc.OTCPK: CASI.F | $2.41M | $0.12 | -9.16% |
Figures last refreshed Oct 4, 2026.